Access one of the largest and most complete Real-World data portfolios in Healthcare
Generate RWE across the drug lifecycle, in a broad range of disease areas
In times of uncertainty and disruption, having access to reliable, fit for purpose Real-World Data and Evidence is more important than ever for healthcare decision-making.
IQVIA Real World Data assets offer:
- Anonymous patient-level data on 800m+ patients across 25+ countries
- Coverage of a broad range of disease areas, including very rare conditions and supplement as needed, with extra investments already made in oncology and genomics.
- Largest variety of global RWD Assets:
| ELECTRONIC MEDICAL RECORDS (EMR) Australia, Belgium, Canada, France, Germany, Italy, Spain, UK, USA ADJUDICATED CLAIMS Australia, Canada, UAE (Dubai), USA, Japan MEDICAL CLAIMS USA, Brazil HOSPITAL Belgium, Portugal, Spain, Poland, UK, USA LAB RESULTS/CONSUMER/ BEHAVIORAL USA |
LONGITUDINAL PRESCRIPTIONS (LRX) Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Japan, Netherlands, Poland, Slovakia, Sweden, Switzerland, UK, USA IQVIA RWD THERAPY AREA ASSETS MULTIPLE THERAPEUTIC AREAS CROSS-SECTIONAL SURVEY Italy, UK ONCOLOGY INTEGRATED EMR USA ONCOLOGY CROSS-SECTIONAL SURVEY Brazil, EU5, China, South Korea, Japan, Mexico, Romania and Saudi Arabia |
ELECTRONIC MEDICAL RECORDS (EMR) UK REGISTRIES Nordic Registry1 (Denmark, Finland, Iceland, Norway, Sweden) 1Need to apply for the data CLAIMS China, France, Germany, Hungary ONCOLOGY EMR Germany OPHTHALMOLOGY EMR UK HOSPITAL CLAIMS/DISCHARGE Japan, UK DATABASE NETWORK Netherlands GENOMIC ALTERATION DATA USA, UK These are a few examples of IQVIA as licensed operator or collaboration partner |
To find out more about IQVIA Real-World Data assets, complete the form and request a virtual Meeting.
Complete this form to request a virtual meeting
Copyright © 2025 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement
